Australia's Nova Eye Medical jumps on Q3 sales surge
** Nova Eye Medical EYE.AX jumps as much as 11.1% to A$0.110; set for biggest intraday pct gain since April 10 ** Medical technology provider's Q3 sales rises 27% y/y ** Q3 U.S. sales jumps 32% y/y, marking its highest ever sales ** EYE last up 6.1%; trims YTD losses to 34.4% (Reporting by Manasi Dasa in Bengaluru) ((Manasi.DasaSundeep@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment